Source: Annual Congress 2012 - Trials in asthma: asthma exacerbations and severe asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Kaur, S. Reynolds, L. Smyth, S. Hall, K. Simpson, S. Fox, D. Singh (Stevenage, United Kingdom). Effect of corticosteroids on lymphocytes from severe asthma patients. Eur Respir J 2012; 40: Suppl. 56, 1784

Member's Comments

No comment yet.

Related content which might interest you: The oral corticosteroid sparing effect of omalizumab in paediatric patients with severe chronic asthma Source: Annual Congress 2010 - Managing asthma and allergic disease in children Year: 2010 Oral corticosteroids in the treatment of exacerbation of severe asthma Source: Virtual Congress 2020 – Exhaled biomarkers of asthma and the asthma burden Year: 2020 Effects of inhaled corticosteroids on cough in asthma patients Source: Eur Respir J 2004; 24: Suppl. 48, 347s Year: 2004 Effect of dupilumab on oral corticosteroid use in severe asthma patients with improving lung function Source: Virtual Congress 2020 – Recent innovations regarding the mechanisms and treatments of asthma Year: 2020 Impact of omalizumab in patients with severe asthma Source: Annual Congress 2009 - Aspects of uncontrolled asthma Year: 2009 Effect of maintenance oral corticosteroids on risk factors for frequent exacerbations in a severe adult asthma population Source: Virtual Congress 2020 – Severe asthma phenotypes and outcomes Year: 2020 Induced sputum in children with mild-moderate persistent asthma: the effect of inhaled corticosteroid treatment Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children Year: 2008 Effect of asthma and asthma medication on the prognosis of patients with COVID-19 Source: Eur Respir J, 57 (3) 2002226; 10.1183/13993003.02226-2020 Year: 2021 Combined therapy of severe osteoporosis for patients with bronchial asthma Source: Eur Respir J 2001; 18: Suppl. 33, 47s Year: 2001 Effect of dupilumab on severe exacerbations in asthma patients with and without lung function improvements Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma Year: 2020 Effects of omalizumab on markers of eosinophilic inflammation in patients with severe allergic asthma Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011 Evolution of patients with severe asthma treated with mepolizumab Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020 Effect of ABPA treatment in severe asthma patients with acute and relapsed disease Source: Virtual Congress 2020 – Advances in asthma treatment Year: 2020 Oral montelukast in patients with acute severe asthma Source: Annual Congress 2007 - Recent advances in our understanding of the treatment of asthma Year: 2007 Effect of an inhaled alpha4-antagonist on the allergen-induced late asthmatic response in patients with mild asthma Source: Eur Respir J 2005; 26: Suppl. 49, 135s Year: 2005 Salmeterol treatment improves corticosteroid responsivness in patients with corticosteroid-insensitive severe asthma Source: Annual Congress 2005 - Improving asthma control in the harder-to-reach population Year: 2005 Characterisation of severe eosinophilic asthma patients who failed Mepolizumab therapy Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020 Immunological effectiveness of N-acetylcystein in complex therapy in severe persistent bronchial asthma patients Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma Year: 2008 Children with mild asthma: do they benefit from inhaled corticosteroids? Source: Eur Respir J 2002; 20: 1470-1475 Year: 2002 Induced sputum in children with persistent asthma: the effect of inhaled corticosteroid treatment Source: Eur Respir J 2006; 28: Suppl. 50, 258s Year: 2006